↓ Skip to main content

Designer drugs 2015: assessment and management

Overview of attention for article published in Addiction Science & Clinical Practice, March 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

policy
1 policy source
twitter
14 X users
facebook
4 Facebook pages
wikipedia
2 Wikipedia pages
reddit
1 Redditor

Citations

dimensions_citation
110 Dimensions

Readers on

mendeley
211 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Designer drugs 2015: assessment and management
Published in
Addiction Science & Clinical Practice, March 2015
DOI 10.1186/s13722-015-0024-7
Pubmed ID
Authors

Michael F Weaver, John A Hopper, Erik W Gunderson

Abstract

Recent designer drugs, also known as "legal highs," include substituted cathinones (e.g., mephedrone, methylone, and methylenedioxypyrovalerone, often referred to as "bath salts"); synthetic cannabinoids (SCs; e.g., Spice); and synthetic hallucinogens (25I-NBOMe, or N-bomb). Compound availability has evolved rapidly to evade legal regulation and detection by routine drug testing. Young adults are the primary users, but trends are changing rapidly; use has become popular among members of the military. Acute toxicity is common and often manifests with a constellation of psychiatric and medical effects, which may be severe (e.g., anxiety, agitation, psychosis, and tachycardia), and multiple deaths have been reported with each of these types of designer drugs. Clinicians should keep designer drugs in mind when evaluating substance use in young adults or in anyone presenting with acute neuropsychiatric complaints. Treatment of acute intoxication involves supportive care targeting manifesting signs and symptoms. Long-term treatment of designer drug use disorder can be challenging and is complicated by a lack of evidence to guide treatment.

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 211 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Canada 1 <1%
Unknown 209 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 43 20%
Student > Master 31 15%
Student > Ph. D. Student 18 9%
Other 16 8%
Researcher 15 7%
Other 45 21%
Unknown 43 20%
Readers by discipline Count As %
Medicine and Dentistry 61 29%
Chemistry 26 12%
Psychology 17 8%
Pharmacology, Toxicology and Pharmaceutical Science 16 8%
Agricultural and Biological Sciences 11 5%
Other 33 16%
Unknown 47 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2022.
All research outputs
#2,266,944
of 25,371,288 outputs
Outputs from Addiction Science & Clinical Practice
#76
of 487 outputs
Outputs of similar age
#28,641
of 277,730 outputs
Outputs of similar age from Addiction Science & Clinical Practice
#2
of 21 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 487 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.6. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,730 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.